-transparent.png){kind=logo}
Approximately 10% of newborn infants with Down Syndrome develop a form of megakaryoblastic leukemia which usually disappears spontaneously during the first months of life. The evidence that this "Transient Leukemia" is truly leukemia includes the following: it is clonal proliferation, it can be fatal and tissue infiltration of leukemic cells occurs. Also in approximately 25% of cases that recover, Acute Megakaryoblastic Leukemia will develop in the first four years of life, which, if not treated, is fatal. Evidence regarding the megakaryoblastic nature of the leukemic cells is presented as well as a description of the lethal forms of the disease. The study of Transient Leukemia is of considerable importance because it can provide insight into both the nature of leukemia and its relation to trisomy 21.
A Zipursky, and
E Brown, and
H Christensen, and
R Sutherland, and
J Doyle
June 2001,
Archives of dermatology,
A Zipursky, and
E Brown, and
H Christensen, and
R Sutherland, and
J Doyle
May 1989,
Wiadomosci lekarskie (Warsaw, Poland : 1960),
A Zipursky, and
E Brown, and
H Christensen, and
R Sutherland, and
J Doyle
January 1998,
Annals of hematology,
A Zipursky, and
E Brown, and
H Christensen, and
R Sutherland, and
J Doyle
July 2011,
Indian journal of pediatrics,
A Zipursky, and
E Brown, and
H Christensen, and
R Sutherland, and
J Doyle
January 2002,
Journal of pediatric hematology/oncology,
A Zipursky, and
E Brown, and
H Christensen, and
R Sutherland, and
J Doyle
January 1988,
The Journal of pediatrics,
A Zipursky, and
E Brown, and
H Christensen, and
R Sutherland, and
J Doyle
May 2015,
European journal of haematology,
A Zipursky, and
E Brown, and
H Christensen, and
R Sutherland, and
J Doyle
November 2008,
Journal of pediatric hematology/oncology,
A Zipursky, and
E Brown, and
H Christensen, and
R Sutherland, and
J Doyle
March 2008,
Blood,
A Zipursky, and
E Brown, and
H Christensen, and
R Sutherland, and
J Doyle
January 2013,
Actas dermo-sifiliograficas,
